In vivo gene transfer of hepatocyte growth factor to skeletal muscle prevents changes in rat kidneys after 5/6 nephrectomy

American Journal of Transplantation

Volumn 2, Issue 9, 2002, Pages 828-836

  Tanaka, Toshiyuki ^a   Ichimaru, Naotsugu ^b   Takahara, Shiro ^b   Yazawa, Koji ^b   Hatori, Motoaki ^a   Suzuki, Kazuhiro ^a   Isaka, Yoshitaka ^b   Moriyama, Toshiki ^b   Imai, Enyu ^b   Azuma, Haruhito ^c   Nakamura, Toshikazu ^b   Okuyama, Akihiko ^b   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Electroporation; Gene transfer; Hepatocyte growth factor

Indexed keywords

PLASMID DNA; SCATTER FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ELECTROPORATION; GENE EXPRESSION; GENE TRANSFER; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY; KIDNEY FIBROSIS; KIDNEY FUNCTION; NEPHRECTOMY; NONHUMAN; RAT; SKELETAL MUSCLE; TISSUE REGENERATION;

ANIMALS; BODY WEIGHT; ELECTROPORATION; GENE TRANSFER TECHNIQUES; HEPATOCYTE GROWTH FACTOR; KIDNEY; MACROPHAGES; MUSCLE, SKELETAL; NEPHRECTOMY; RATS;

EID: 0036820428     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20904.x     Document Type: Article

References (52)

1. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459.
2. Russell WE, Mcogowan JA, Bucher NLR. Partial characterization of hepatocyte growth factor from rat platelets. J Cell Physiol 1984; 119: 183-192.
3. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in culture. Proc Natl Acad Sci U S A 1986; 83: 6489-6493.
4. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 1987; 224: 311-316.
5. Hirono S, Sakiyama O, Takahashi K, Miyazaki H, Hashimoto S, Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-419.
6. Zarnegar R, Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res 1989; 49: 3314-3320.
7. Seki T, Shimonishi M, Sugimura A, Tashiro K, Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-443.
8. Seki T, Shimonishi M, Shimizu S, Nakamura T. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci U S A 1990; 87: 3200-3204.
9. Matsumoto K, Nakamura T. Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases. Kidney Int 2001; 59: 2023-2038.
10. Mizuno S, Matsumoto K, Kurosawa T, Mizuno-Horikawa Y, Nakamura T. Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice. Kidney Int 2000; 57: 937-948.
11. Mizuno S, Matsumoto K, Nakamura T. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 2001; 59: 1304-1314.
12. Mizuno S, Kurosawa T, Matsumoto K, Mizuno-Horikawa Y, Okamoto M, Nakamura T. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest 1998; 101: 1827-1834.
13. Liu Y, Rajur K, Tolbert E, Dworkin LD. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 2000; 58: 2028-2043.
14. Matsumoto K, Mizuno S, Nakamura T. Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics. Curr Opin Nephrol Hypertens 2000; 9: 395-402.
15. Ichimaru N, Wang JD, Moriyama T, Waaga AM, Kitamura M, Otsuki Y et al. Hepatocyte growth factor prevents the development of chronic allograft nephropathy in rats. J Am Soc Nephrol 2001; 12: 1280-1292.
16. Liu ML, Mars WM, Zarnegar R, Michalopoulos GK. Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver. Am J Pathol 1994; 144: 129-140.
17. Kelley VR, Sukhatme VP. Gene transfer in the kidney. Am J Physiol 1999; 276 (1 Part 2): F1-F9.
18. Imai E, Isaka Y. New paradigm of gene therapy: skeletal - muscle-targeting gene therapy for kidney disease. Nephron 1999; 83: 296-300.
19. Nakanishi K, Sawa Y, Morishita R et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226-230.
20. Rockey DC. Gene therapy for hepatic fibrosis-bringing treatment into the new millennuim. Hepatology 1999; 30: 816-818.
21. Fujimoto J. Reversing liver cirrhosis: impact of gene therapy for liver cirrhosis. Gene Ther 1999; 6: 305-306.
22. Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1: 841-845.
23. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867-870.
24. Titomirov AV, Sukharev S, Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1991; 1088: 131-134.
25. Muramatsu T, Mizutani Y, Ohmori Y, Okumura J. Comparison of three nonviral transfection methods for foreign gene expression in early chicken embryos in ovo. Biochem Biophys Res Commun 1997; 230: 376-380.
26. Moradpour D, Gilbert R, Wands J, Nicolau C. In vivo gene electroinjection and expression in rat liver. FEBS Lett 1996; 389: 225-228.
27. Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998; 16: 168-171.
28. Minagawa R, Rikimaru T, Hamatsu T, Tanaka S, Shirabe K, Miyazaki JI, Sugimachi K. Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res 2001; 61: 1005-1012.
29. Akagi Y, Sudo T, Ohno N, Imai E, Hori M. Electroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis. Kidney Int 2001; 59: 2134-2145.
30. Tsujie M, Isaka Y, Nakamura H, Imai E, Hori M. Electroporation-mediated gene transfer that targets glomeruli. J Am Soc Nephrol 2001; 12: 949-954.
31. Crary GS, Swan SK, O'Donnell MP, Kasiske BL, Katz SA, Keane WF. The angiotensin II receptor antagonist losartan reduces blood pressure but not renal injury in obese Zucker rats. J Am Soc Nephrol 1995; 6: 1295-1299.
32. Fogo AB. Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol 1999; 7: 147-159.
33. Fogo AB. Progression and potential regression of glomerulosclerosis. Kidney Int 2001; 59: 804-819.
34. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995; 129: 1177-1180.
35. Matsumoto K, Nakamura T. Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun 1997; 239: 639-644.
36. Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol 1993; 265: F61-F69.
37. Kawaida K, Matsumoto K, Shimazu H, Nakamura T. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci U S A 1994; 91: 4357-4361.
38. Miller SB, Martin DR, Kissane J, Hammerman MR. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol 1994; 266: F129-F134.
39. Matsuda Y, Matsumoto K, Ichida T, Nakamura T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 1995; 118: 643-649.
40. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 1996; 24: 636-642.
41. Sakai T, Abe T, Satoh K, Matsumoto K, Nakamura T, Takahashi T, Nukiwa T. Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med 1997; 156: 1937-1944.
42. Tarasova N, Hirschi C, Flogerzi B, Matsumoto K, Nakamura T, Halter F. Roles of hepatocyte growth factor and its receptor Met during gastric ulcer healing in rats. Gastroenterology 1997; 113: 1858-1872.
43. Kosai K. Matsumoto K, Funakoshi H, Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 1999; 30: 151-159.
44. Tahara M, Matsumoto K, Nukiwa T, Nakamura T. Hepatocyte growth factor leads to recovery from alcohol-induced fatty liver in rats. J Clin Invest 1999; 103: 313-320.
45. Ichimaru N, Hongsi J, Kokado Y et al. Effect of hepatocyte growth factor on tacrolimus-induced nephrotoxicity in spontaneously hypertensive rats. Transpl Int 1999; 12: 27-32.
46. Kaneda Y, Imai E, Noble NA, Border WA. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2: 418-423.
47. Morioka CY, Takahara S, Yamato E, Dono K, Watanabe A. Attenuated acute liver injury in mice by naked HGF gene transfer into skeletal muscle with electroporation. Gut 2002; 50: 558-562.
48. van Goor H, Fidler V, Weening JJ, Grond J. Determinants of focal and segmental glomerulosclerosis in the rat after renal ablation. Evidence for involvement of macrophages and lipids. Lab Invest 1991; 64: 754-765.
49. Yoshimura A, Pritzl P, Gordon K et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 41: 297-309.
50. Schiller B, Moran J. Focal glomerulosclerosis in the remnant kidney model: An inflammatory disease mediated by cytokines. Nephrol Dial Transplant 1997; 12: 430-437.
51. Cooper ME, Gilbert RE, Atkins RC, Lan HY. Macrophage and myofibroblast proliferation in remnant kidney: Role of angiotensin II. Kidney Int 1997; 52: S221-S225.
52. Corna D, Perico N, Bertani T, Remuzzi G. Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease. J Am Soc Nephrol 1999; 10: 804-813.